Premium
ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus–related thrombotic thrombocytopenic purpura
Author(s) -
Gunther Karen,
Garizio Dominique,
Nesara Paul
Publication year - 2007
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/j.1537-2995.2007.01346.x
Subject(s) - adamts13 , thrombotic thrombocytopenic purpura , von willebrand factor , medicine , immunology , immunopathology , autoantibody , platelet , gastroenterology , antibody
BACKGROUND: Little is known about the pathophysiology of human immunodeficiency virus (HIV)‐related thrombotic thrombocytopenic purpura (TTP). It is generally assumed that acquired ADAMTS13 deficiency is due to the presence of autoantibody inhibitors, but limited data are available regarding ADAMTS13 activity and inhibitors in such patients. STUDY DESIGN AND METHODS: By use of a collagen‐binding assay, ADAMTS13 activity was analyzed at presentation in 20 patients with HIV‐related TTP. The presence of inhibitors in patients with reduced ADAMTS13 activity was assessed with mixing studies. The correlation between ADAMTS13 activity and inhibitors and other laboratory and clinical parameters was assessed. RESULTS: The patients fell clearly into two groups with regard to ADAMTS13 activity. Six patients (30%) had activity within the normal range, whereas the remaining 14 patients had severely reduced levels. Of the patients with reduced activity, only 5 patients had a detectable inhibitor whereas 8 showed no evidence of an inhibitor. There was significant correlation between normal ADAMTS13 activity and lower CD4 counts (p = 0.049). von Willebrand factor (VWF) antigen levels were significantly higher in patients with reduced ADAMTS13 activity (p = 0.03). Low activity in the absence of a detectable inhibitor was associated with significantly higher D‐dimer levels (p = 0.01) and worse clinical outcome. CONCLUSION: The heterogeneity with regard to ADAMTS13 activity and the absence of inhibitors in the majority of patients indicate that other factors are important in the pathogenesis of HIV‐related TTP. VWF release and localized coagulation activation due to direct viral or cytokine‐mediated endothelial cell injury is likely to be playing a major role.